Clinical Potential of Targeting Fibroblast Growth Factor-23 and αKlotho in the Treatment of Uremic Cardiomyopathy.
Law JP, Price AM, Pickup L, Radhakrishnan A, Weston C, Jones AM, McGettrick HM, Chua W, Steeds RP, Fabritz L, Kirchhof P, Pavlovic D, Townend JN, Ferro CJ.
Law JP, et al.
J Am Heart Assoc. 2020 Apr 7;9(7):e016041. doi: 10.1161/JAHA.120.016041. Epub 2020 Mar 26.
J Am Heart Assoc. 2020.
PMID: 32212912
Free PMC article.
Review.